Drug safety on trial

Por Greener, Mark
Publicado em 2005

Engendering creativity in the biomedical sciences

Por Greener, Mark
Publicado em 2005

Taking on creationism. Which arguments and evidence counter pseudoscience?

Por Greener, Mark
Publicado em 2007

First do no harm. Improving drug safety through legislation and independent research

Por Greener, Mark
Publicado em 2008

Bitter medicine. New regulations aim to address the dearth of clinical safety trials for drugs used in children

Por Greener, Mark
Publicado em 2008

Is the grass greener on the other side? Encouraging the development of synthetic biology in Europe

Por Greener, Mark
Publicado em 2008

It's life, but just as we know it

Por Greener, Mark
Publicado em 2008

The good, the bad and the ugly red tape of biomedical research. How could regulators lower bureaucratic hurdles in clinical research without compromising the safety of patients?

Por Greener, Mark
Publicado em 2009

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus

Por Feher, Michael, Greener, Mark, Munro, Neil
Publicado em 2013

Botulinum Toxin in Aesthetic Medicine: Myths and Realities

Por Dover, Jeffrey S., Monheit, Gary, Greener, Mark, Pickett, Andy
Publicado no Dermatol Surg (2018)

Development and Application of an eDNA Method to Detect the Critically Endangered Trinidad Golden Tree Frog (Phytotriades auratus) in Bromeliad Phytotelmata

Por Brozio, Sarah, Manson, Chloe, Gourevitch, Eleanor, Burns, Thomas J., Greener, Mark S., Downie, J. Roger, Hoskisson, Paul A.
Publicado no PLoS One (2017)